These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24023802)

  • 1. IKKα/CHUK regulates extracellular matrix remodeling independent of its kinase activity to facilitate articular chondrocyte differentiation.
    Olivotto E; Otero M; Astolfi A; Platano D; Facchini A; Pagani S; Flamigni F; Facchini A; Goldring MB; Borzì RM; Marcu KB
    PLoS One; 2013; 8(9):e73024. PubMed ID: 24023802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors.
    Borzí RM; Olivotto E; Pagani S; Vitellozzi R; Neri S; Battistelli M; Falcieri E; Facchini A; Flamigni F; Penzo M; Platano D; Santi S; Facchini A; Marcu KB
    Arthritis Rheum; 2010 Aug; 62(8):2370-81. PubMed ID: 20506238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes.
    Olivotto E; Borzi RM; Vitellozzi R; Pagani S; Facchini A; Battistelli M; Penzo M; Li X; Flamigni F; Li J; Falcieri E; Facchini A; Marcu KB
    Arthritis Rheum; 2008 Jan; 58(1):227-39. PubMed ID: 18163512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible knockout of CHUK/IKKα in adult chondrocytes reduces progression of cartilage degradation in a surgical model of osteoarthritis.
    Culley KL; Lessard SG; Green JD; Quinn J; Chang J; Khilnani T; Wondimu EB; Dragomir CL; Marcu KB; Goldring MB; Otero M
    Sci Rep; 2019 Jun; 9(1):8905. PubMed ID: 31222033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.
    Liu-Bryan R; Terkeltaub R
    Arthritis Rheum; 2010 Jul; 62(7):2004-12. PubMed ID: 20506365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the Mechanisms of Hypertrophy-Induced Matrix Mineralization and Modifications in Articular Chondrocytes.
    Jaabar IL; Foley B; Mezzetti A; Pillier F; Berenbaum F; Landoulsi J; Houard X
    Calcif Tissue Int; 2024 Sep; 115(3):269-282. PubMed ID: 38918254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differentiation of prehypertrophic into hypertrophic chondrocytes drives an OA-remodeling program and IL-34 expression.
    van Eegher S; Perez-Lozano ML; Toillon I; Valour D; Pigenet A; Citadelle D; Bourrier C; Courtade-Gaïani S; Grégoire L; Cléret D; Malbos S; Nourissat G; Sautet A; Lafage-Proust MH; Pastoureau P; Rolland-Valognes G; De Ceuninck F; Berenbaum F; Houard X
    Osteoarthritis Cartilage; 2021 Feb; 29(2):257-268. PubMed ID: 33301945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis.
    Loeser RF; Yammani RR; Carlson CS; Chen H; Cole A; Im HJ; Bursch LS; Yan SD
    Arthritis Rheum; 2005 Aug; 52(8):2376-85. PubMed ID: 16052547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13.
    Attur M; Yang Q; Shimada K; Tachida Y; Nagase H; Mignatti P; Statman L; Palmer G; Kirsch T; Beier F; Abramson SB
    FASEB J; 2015 Oct; 29(10):4107-21. PubMed ID: 26092928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV; Squires G; Poole AR
    J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrocyte-intrinsic Smad3 represses Runx2-inducible matrix metalloproteinase 13 expression to maintain articular cartilage and prevent osteoarthritis.
    Chen CG; Thuillier D; Chin EN; Alliston T
    Arthritis Rheum; 2012 Oct; 64(10):3278-89. PubMed ID: 22674505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NAD-Dependent Deacetylase Sirtuin-1 Regulates the Expression of Osteogenic Transcriptional Activator Runt-Related Transcription Factor 2 (Runx2) and Production of Matrix Metalloproteinase (MMP)-13 in Chondrocytes in Osteoarthritis.
    Terauchi K; Kobayashi H; Yatabe K; Yui N; Fujiya H; Niki H; Musha H; Yudoh K
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular injection of microRNA-140 (miRNA-140) alleviates osteoarthritis (OA) progression by modulating extracellular matrix (ECM) homeostasis in rats.
    Si HB; Zeng Y; Liu SY; Zhou ZK; Chen YN; Cheng JQ; Lu YR; Shen B
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1698-1707. PubMed ID: 28647469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: implications for development and arthritis.
    Tchetina EV; Kobayashi M; Yasuda T; Meijers T; Pidoux I; Poole AR
    Matrix Biol; 2007 May; 26(4):247-58. PubMed ID: 17306969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runx2 is required for hypertrophic chondrocyte mediated degradation of cartilage matrix during endochondral ossification.
    Rashid H; Chen H; Javed A
    Matrix Biol Plus; 2021 Dec; 12():100088. PubMed ID: 34805821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro.
    Wang L; Almqvist KF; Veys EM; Verbruggen G
    Osteoarthritis Cartilage; 2002 Mar; 10(3):188-98. PubMed ID: 11869079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways.
    Bradley EW; Drissi MH
    Mol Endocrinol; 2010 Aug; 24(8):1581-93. PubMed ID: 20573686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPTLC2 ameliorates chondrocyte dysfunction and extracellular matrix metabolism disturbance in vitro and in vivo in osteoarthritis.
    Lü G; Wu R; Wang B; Li L; Li Y; Li X; He H; Wang X; Kuang L
    Exp Cell Res; 2023 Apr; 425(1):113524. PubMed ID: 36828166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation.
    Ijiri K; Zerbini LF; Peng H; Correa RG; Lu B; Walsh N; Zhao Y; Taniguchi N; Huang XL; Otu H; Wang H; Wang JF; Komiya S; Ducy P; Rahman MU; Flavell RA; Gravallese EM; Oettgen P; Libermann TA; Goldring MB
    J Biol Chem; 2005 Nov; 280(46):38544-55. PubMed ID: 16144844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties.
    Gabay O; Sanchez C; Salvat C; Chevy F; Breton M; Nourissat G; Wolf C; Jacques C; Berenbaum F
    Osteoarthritis Cartilage; 2010 Jan; 18(1):106-16. PubMed ID: 19786147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.